Investing Profile

Peter Dudek

InvestorVC
President & Managing Partner, MRL Ventures Fund at Merck
mrlv.comCambridge, Massachusetts
Photo of Peter Dudek, Managing Partner at M Ventures (Merck)
Your Intro Paths to Peter Dudek

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Peter is a member of
NewCo Network
1599 CONNECTIONS
Novartis Network
53 CONNECTIONS
The University of British Columbia Network
49 CONNECTIONS
Merck Network
36 CONNECTIONS
Merck Network
36 CONNECTIONS

Find Peter Dudek on

cb
Current Investing Position
M Ventures (Merck) Managing Partner
Investment Range
$15.0M - $20.0M
Sweet Spot
$17.5M
Investments On Record
5
Current Fund Size
€600M

Peter Dudek is on these Sector & Stage Rankings

Peter Dudek's Investments On Record (3)

CompanyStageDateRound SizeTotal Raised
Carisma Therapeutics
Series CSep 2022$30M
Series BMar 2021$12M
$150M
Co-investors: Margarita Chavez (AbbVie Ventures), Dr. Regina Hodits (Wellington Partners), Geeta Vemuri (Agent Capital)
Mozart Therapeutics
Series AOct 2021$55M
$80M
Co-investors: Jasmina Marjanovic (Takeda Ventures, Inc.), Lucio Iannone (Leaps by Bayer), Henrijette Richter (Sofinnova Partners), Steven Gillis (ARCH Venture Partners)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
$330M
Co-investors: Andrew Hack (Bain Capital Ventures), Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Nancy Hong (San Diego Symphony), Jack Kenney (SV Health Investors)

Peter Dudek's Experience

Research Assistant BC Centre for Disease ControlPresent
Doctoral Student Université de GenèvePresent
Post Doctoral Fellow University of OxfordPresent
Intern Analyst / Consultant NovartisPresent
Consultant NewCoPresent
Associate COFRA Holding AGPresent
Principal Wellington PartnersPresent
Board Observer Kymera TherapeuticsPresent
Board Director Xilio Therapeutics, Inc.Present
Partner, MRL Ventures Fund MerckPresent
Board Observer Imago BioSciences, Inc.Present
Board Observer Xilio Therapeutics, Inc.Present
Board Observer HotSpot Therapeutics, Inc.Present
Board Observer LifeMine TherapeuticsPresent
Board Observer Carisma TherapeuticsPresent
Board Director Caraway Therapeutics, Inc.Present
Board Director Therini Bio, Inc.Present
Board Director AmbAgon TherapeuticsPresent
Board Director Mozart Therapeutics, Inc.Present
President & Managing Partner, MRL Ventures Fund MerckPresent
Board Director Tallac TherapeuticsPresent
Board Observer Photys TherapeuticsPresent
Board Director InduProPresent
Board Observer InsamoPresent
Board Observer Aktis OncologyPresent

Peter Dudek's Education

Capilano University Associate of Science Science
The University of British Columbia Bachelor of Science (Hons) Molecular Microbiology and Immunology
University of Geneva Doctor of Philosophy Cell Biology
Saïd Business School, University of Oxford Building a Business Medical Innovation

Founders who looked at Peter Dudek's profile also looked at these Scouts & Angels

Photo of Christopher Priebe, Angel

Photo of Justin Waldron, Angel

Photo of Brad Holden, Managing Partner

Photo of Morgan Beller, General Partner